« Back
Home /
Grazoprevir

Grazoprevir

Manufacturer	MedChem Express
Category	Inhibitors & Compound Libraries Small Molecules
Type	Inhibitors
Specific against	other
Clone	N/A
Amount	50 mg
Item no.	HY-15298-50mg
Targets	HCV Protease; HCV; SARS-CoV
CASRN	1350514-68-9
eClass 6.1	30220300
eClass 9.0	32160605
Available
Product Description	Grazoprevir (MK-5172) is a selective inhibitor of Hepatitis C virus NS3/4a protease with broad activity across genotypes and resistant variants, with Kis of 0.01 nM (gt1b), 0.01 nM (gt1a), 0.08 nM (gt2a), 0.15 nM (gt2b), 0.90 nM (gt3a), respectively[1][2]. Grazoprevir inhibits SARS-CoV-2 3CLpro activity[3].
StorageTemperature	-20°C, 3 years; 4°C, 2 years (Powder)
Shipping	Room Temperature
Manufacturers Applications	COVID-19-anti-virus
MolecularWeight	766.90
Clinical_Information	Launched
Manufacturers Research_Area	Infection
Solubility	DMSO : 50 mg/mL (ultrasonic)\|Ethanol : 66.67 mg/mL (ultrasonic)
Manufacturers Target	HCV; HCV Protease; SARS-CoV
Pathway	Anti-infection; Metabolic Enzyme/Protease
Manufacturers Product type	Reference compound

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

HY-15298-50mg-safety-datasheet.pdf